Quest Diagnostics Incorporated reported significant financial growth in its latest quarterly results, with net revenues reaching $3.097 billion for the three months ended September 30, 2026, a 10% increase from $2.816 billion in the same period last year. For the nine months ending September 30, 2026, revenues totaled $9.035 billion, up from $8.229 billion in 2025, marking a 9.8% year-over-year increase. The company's operating income also saw a notable rise, reaching $479 million for the third quarter, compared to $386 million in the prior year, while net income attributable to Quest Diagnostics increased to $312 million from $245 million.

The growth in revenue was primarily driven by a 10.2% increase in the Diagnostic Information Services (DIS) segment, which accounted for over 95% of total revenues. This segment benefited from a 14.5% increase in requisition volume, largely attributed to new partnerships with Corewell Health and increased laboratory testing at Fresenius Medical Care dialysis clinics. However, revenue per requisition decreased by 4.2%, influenced by a shift in business mix towards more routine tests. The Diagnostic Solutions (DS) segment remained stable, contributing $62 million in revenues, a slight increase from $61 million in the previous year.

Operationally, Quest Diagnostics has been focusing on strategic initiatives such as the "Invigorate" program, aimed at enhancing productivity and achieving annual cost savings of 3%. The company incurred $14 million in restructuring charges during the nine months ended September 30, 2026, primarily related to workforce reductions. Additionally, the company completed a significant acquisition in January 2026, forming a new entity with Corewell Health to enhance laboratory testing capabilities in Michigan.

As of September 30, 2026, Quest Diagnostics reported total assets of $17.221 billion, up from $16.225 billion at the end of 2025. The company also improved its cash position, with cash and cash equivalents increasing to $797 million from $420 million. The total employee headcount remained stable at approximately 50,000. Looking ahead, Quest Diagnostics anticipates continued growth driven by its strategic partnerships and operational efficiencies, while also navigating challenges related to market conditions and reimbursement pressures.

About QUEST DIAGNOSTICS INC

Quest Diagnostics is a leading provider of diagnostic testing and information services, serving healthcare providers, hospitals, patients, and payers primarily in the U.S. The company offers routine, advanced, and molecular diagnostics, leveraging extensive data assets, innovative technology, and a broad network of laboratories and patient centers. Its core value lies in delivering high-quality, accessible insights to improve health outcomes and support value-based care.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov